Keer, Harold External Author

Publications

Sort by

Selected publications

  • Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric CancerPLoS ONE2013 Academic Article GET IT
    Times cited: 106